Matthew Lankiewicz, MD

Dr. Rakhi P. Naik is the Associate Director for the Division of Hematology at Johns Hopkins University. She also serves as Director of the Fellowship Hematology Track and Director of Organ Systems Foundation of Medicine (OSFM), the largest pre-clerkship course in the medical school. She holds an undergraduate degree in Biomedical & Electrical Engineering from Duke University, an M.D. with Honors in Research from Cornell University, and a Masters in Health Science (MHS) from the Johns Hopkins Bloomberg School of Public Health. She completed her Internal Medicine Residency and Hematology Fellowship training at Johns Hopkins, where she also served as Assistant Chief of Service (Chief Resident). Dr. Naik specializes in the treatment of adult patients with wide-array of non-malignant (classical) hematologic diseases, including autoimmune cytopenias, coagulation disorders, hemoglobinopathies, and myeloid disorders. Her primary research expertise is in sickle cell disease and sickle cell trait. Dr. Naik served as the inaugural Chair of the American Society of Hematology (ASH) Hematology-Focused Training Program Consortium, which aims to create innovative training pathways and curriculum to increase trainee recruitment into academic hematology.

Richard Battafarano, M.D., Ph.D., joins the Johns Hopkins Department of Surgery as director of the Division of General Thoracic Surgery and the first regional director of general thoracic surgery. He comes to Johns Hopkins from University of Maryland Medical System, where he was chief of the Division of Thoracic Surgery. Dr. Battafarano specializes in the treatment of benign and malignant diseases and lesions of the chest, including minimally invasive operations such as video-assisted thoracoscopic surgery (VATS) for lung and esophageal cancers. He also has a special interest in treating Barrett's esophagus, emphysema, mesothelioma and paraesophageal hernias. The focus of Dr. Battafarano's basic and translational research includes outcomes in the surgical management of early stage lung cancer patients with neuroendocrine histology, optimal management of lung cancer patients with mediastinal lymph node metastases, and the effect of survivin overexpression in the development of esophageal cancer. Dr. Battafarano sees patients at The Johns Hopkins Hospital and the Johns Hopkins Health Care & Surgery Centers at Green Spring Station and at White Marsh. To support Dr. Battafarano's research, visit: https://secure.jhu.edu/form/Battafarano

Joseph C. Murray, M.D., Ph.D. is an Assistant Professor of Oncology at the Sidney Kimmel Comprehensive Cancer at Johns Hopkins in the Upper Aerodigestive Cancer Division (UAD). He is Co-Director of the Lung Cancer Precision Medicine Center of Excellence (PMCOE) and directs the UAD Immunotherapy Database.Dr. Murray received his undergraduate degree in Molecular Cell Biology from the University of California, Berkeley in 2003. After working in the biotechnology industry, he went on to receive his medical and graduate degree in Interdisciplinary Tumor Biology at Georgetown University School of Medicine in 2015. After completing internship and residency in the Osler Medical Residency Training Program at Johns Hopkins Hospital, he remained at Johns Hopkins to complete his fellowship in Medical Oncology in the Sidney Kimmel Comprehensive Cancer Center.Dr. Murray conducts translational research in cancer genomics, liquid biopsy, and immunology in non-small cell lung cancer. He also has expertise in antibody-based immunotherapy, molecular and cell biology, and bioinformatics. He integrates research through the Lung Cancer PMCOE and UAD Immunotherapy Database to conduct observational clinical studies in real-world populations of patients with thoracic cancer. He cares for patients primarily at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center at Bayview Medical Center.